Paper36910221
Thiostrepton, a resurging drug inhibiting the stringent response to counteract antibiotic-resistance and expression of virulence determinants in Neisseria gonorrhoeae.
Talà A and 5 others. Front Microbiol, 2023. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Thiostrepton, a resurging drug inhibiting the stringent response to counteract antibiotic-resistance and expression of virulence determinants in Neisseria gonorrhoeae. Papers, record 36910221. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36910221
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thiostrepton, a resurging drug inhibiting the stringent response to counteract antibiotic-resistance and expression of virulence determinants in Neisseria gonorrhoeae.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30,980,069 | Definitions and guidelines for research on antibiotic persistence. | Nat Rev Microbiol | 2019 | https://conductscience.org/library/papers/30980069 | PubMed |
| 2 | 22,179,135 | Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. | Nat Genet | 2011 | https://conductscience.org/library/papers/22179135 | PubMed |
| 3 | 29,475,943 | Guanosine tetra- and pentaphosphate increase antibiotic tolerance by reducing reactive oxygen species production in Vibrio cholerae. | J Biol Chem | 2018 | https://conductscience.org/library/papers/29475943 | PubMed |
| 4 | 29,621,310 | Mutations in Neisseria gonorrhoeae grown in sub-lethal concentrations of monocaprin do not confer resistance. | PLoS One | 2018 | https://conductscience.org/library/papers/29621310 | PubMed |
| 5 | 31,795,866 | Antibiotic resilience: a necessary concept to complement antibiotic resistance? | Proc Biol Sci | 2019 | https://conductscience.org/library/papers/31795866 | PubMed |
| 6 | 29,390,134 | The ribosomal A-site finger is crucial for binding and activation of the stringent factor RelA. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29390134 | PubMed |
| 7 | 24,532,069 | A new subfamily of polyphosphate kinase 2 (class III PPK2) catalyzes both nucleoside monophosphate phosphorylation and nucleoside diphosphate phosphorylation. | Appl Environ Microbiol | 2014 | https://conductscience.org/library/papers/24532069 | PubMed |
| 8 | 24,336,937 | Two small (p)ppGpp synthases in Staphylococcus aureus mediate tolerance against cell envelope stress conditions. | J Bacteriol | 2014 | https://conductscience.org/library/papers/24336937 | PubMed |
| 9 | 4,793,881 | Activity of five aminoglycoside antibiotics in vitro against gram-negative bacilli and Staphylococcus aureus. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4793881 | PubMed |
| 10 | 34,863,996 | The bacterial thiopeptide thiostrepton. An update of its mode of action, pharmacological properties and applications. | Eur J Pharmacol | 2022 | https://conductscience.org/library/papers/34863996 | PubMed |
| 11 | 34,753,108 | Current mechanistic understanding of intermembrane lipid trafficking important for maintenance of bacterial outer membrane lipid asymmetry. | Curr Opin Chem Biol | 2021 | https://conductscience.org/library/papers/34753108 | PubMed |
| 12 | 4,576,413 | Effect of serine hydroxamate on phospholipid synthesis in Escherichia coli. | J Bacteriol | 1973 | https://conductscience.org/library/papers/4576413 | PubMed |
| 14 | 115,831 | Effects of low ampicillin concentrations on penicillin sensitive and beta-lactamase producing strains of Neisseria gonorrhoeae. | J Antimicrob Chemother | 1979 | https://conductscience.org/library/papers/115831 | PubMed |
| 15 | 32,436,729 | The Use of Gentamicin for Treatment of Urogenital and Extragenital Gonorrhea: A Systematic Review of Efficacy Data. | Ann Pharmacother | 2020 | https://conductscience.org/library/papers/32436729 | PubMed |
| 16 | 31,626,749 | Bacterial Heterogeneity and Antibiotic Survival: Understanding and Combatting Persistence and Heteroresistance. | Mol Cell | 2019 | https://conductscience.org/library/papers/31626749 | PubMed |
| 17 | 24,445,304 | Thiopeptide antibiotics: retrospective and recent advances. | Mar Drugs | 2014 | https://conductscience.org/library/papers/24445304 | PubMed |
| 18 | 18,406,324 | Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. | Mol Cell | 2008 | https://conductscience.org/library/papers/18406324 | PubMed |
| 19 | 24,545,143 | Antibacterial spectrum of a new antibiotic, thiostrepton; disc sensitivity studies. | Antibiot Chemother (Northfield) | 1959 | https://conductscience.org/library/papers/24545143 | PubMed |
| 20 | 29,058,643 | The sibling sRNAs NgncR_162 and NgncR_163 of Neisseria gonorrhoeae participate in the expression control of metabolic, transport and regulatory proteins. | Microbiology (Reading) | 2017 | https://conductscience.org/library/papers/29058643 | PubMed |
| 21 | 6,179,924 | Control of rRNA and tRNA syntheses in Escherichia coli by guanosine tetraphosphate. | J Bacteriol | 1982 | https://conductscience.org/library/papers/6179924 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,070,520 | Identification of novel inhibitors targeting serine acetyltransferase from Neisseria gonorrhoeae. | Comput Struct Biotechnol J | 2025 | https://conductscience.org/library/papers/40070520 | PubMed |
| 39,513,865 | Beyond Inflammation: Role of Pyroptosis Pathway Activation by Gram-Negative Bacteria and Their Outer Membrane Vesicles (OMVs) in the Interaction with the Host Cell. | Cells | 2024 | https://conductscience.org/library/papers/39513865 | PubMed |
| 39,468,287 | Thiazoplanomicin, a new thiazolyl peptide antibiotic from the leaf-litter actinomycete Actinoplanes sp. MM794L-181F6. | J Antibiot (Tokyo) | 2025 | https://conductscience.org/library/papers/39468287 | PubMed |
| 38,691,668 | Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/38691668 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MAFA | 389,692 | PubTator's text mining | https://conductscience.org/library/genes/389692 | NCBI Gene |
| PRNP | 5,621 | PubTator's text mining | https://conductscience.org/library/genes/5621 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36910221
GET https://conductscience.org/api/papers/v1/36910221/references?page=2